Compound Radar

Baxter International Inc. (BAX) Stock Analysis

Price $24.86
Market cap $12.85B
Next earnings Oct 29, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

44
44/100 Avoid
  • Financial Health 30
  • Profitability 50
  • Business Quality 60
  • Balance Sheet 40
  • Cash Flow 45

Why this rating?

Health 44/100 — Avoid

Strongest Business Quality 60/100
Softest Financial Health 30/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Baxter International Inc. (BAX) is a Medical Instruments & Supplies company in the Healthcare sector. Compound Radar rates Baxter International Inc. 44/100 (Avoid) due to solid business quality, steady revenue growth, and elevated leverage.

Investment profile

  • Quality Moderate
  • Growth Moderate
  • Balance Sheet Stretched
  • Valuation Attractive

Financial highlights

Valuation

  • Forward P/E 12.21
  • EV/Revenue 1.82

Profitability

  • Revenue Growth 5.3%
  • Gross Margin 34.1%
  • Operating Margin 14.4%
  • Net Margin -9.3%
  • ROE -14.4%

Financial strength

  • Cash $2.15B
  • Debt $9.67B
  • Net Cash $-7.52B
  • Free Cash Flow $323.00M
  • Current Ratio 1.95

Similar companies

Peers in Medical Instruments & Supplies, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Instruments & Supplies →

FAQ

How Compound Radar scores and tracks Baxter International Inc. (BAX).

View Methodology & FAQ →